The amino acid sequence of the light-chain variable region of a rabbit antibody against the streptococcal group a variant polysaccharide (antibody K16-167)  by Riesen, Walter F. & Braun, Dietmar G.
Volume 75, number 1 FEBS LETTERS March 1977 
THE AMINO ACID SEQUENCE OF THE LIGHT-CHAIN VARIABLE REGION OF A RABBIT 
ANTIBODY AGAINST THE STREPTOCOCCAL GROUP A VARIANT POLYSACCHARIDE 
(ANTIBODY K16-167) 
Walter F. RIESEN and Dietmar G. BRAUN 
Base1 Institute for Immunology, 487 Grenzacherstrasse, Postfach 4005 Base1 5, Switzerland 
Received 10 February 1977 
1. Introduction 
Comparative studies of the amino acid sequences of 
myeloma proteins have contributed significantly to 
the knowledge of the structure of antibody molecules 
and have revealed an apparently limitless variability of 
the immunoglobulins. The mechanism by which this 
variability is generated is still an unresolved problem. 
Amino acid sequence analysis of homogeneous 
antibodies induced by antigens of great epitope homo- 
geneity and derived from animals of defined genetic 
background are expected to provide insights into the 
generation of antibody diversity. Rabbits selectively 
bred for oligoclonal responses against the strepto- 
coccal group A variant polysaccharide (Av-CHO) have 
proved a particularly fruitful system for the analysis 
of amino acid sequence patterns [l-4]. 
A previous report from this laboratory has com- 
pared the amino acid sequences of several variable 
halves of light-chains derived from anti-Av-CHO 
antibodies [4]. We would like to present in detail the 
amino acid sequence of the variable region of the 
light-chain ( VL) of the rabbit antibody K16-167, 
another anti-Av-CHO antibody of the b4 allotype. 
2. Materials and methods 
Rabbit K16-167 was immunized with strepto- 
coccal group A variant (strain A486 variant, M-) 
vaccine as described [.5]. The antibody was isolated 
from the hyperimmune serum by repeated preparative 
agarose block electrophoresis [6]. 
Heavy- and light-chains were prepared by partial 
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reduction and alkylation, followed by separation on 
Sephadex G-100 in 1 M acetic acid [7] . Complete 
reduction and alkylation with iodo-[2-‘4C]acetic 
acid was done according to O’Donnell et al. [8]. 
Succinylation of fully reduced and alkylated light- 
chain was carried out as outlined by Klotz [9]. 
Citraconylation was done by the method of Gibbons 
and Perham [lo] . The unblocking of citraconyl- 
peptides was effected by incubation in acetate buffer, 
pH 4.2, for 6 h at 37°C [ 1 l] . 
Tryptic digestion was performed for 4 h by using a 
1: 100 ratio (w/w) of TPCK-trypsin to protein in the 
presence of 1% NI&HCOa . Hydrolyses with carboxy- 
peptidases A and B were conducted as recommended 
by Ambler [12]. 
Preparative high-voltage paper electrophoresis was 
done according to Press et al. [ 131. Peptides were 
detected as described elsewhere [14,15]. They were 
eluted from the paper with 0.02 M N&OH. 
Automated sequence determination of the 
N-terminal section of the light-chain and of large 
peptides was performed as previously described [ 161. 
Small peptides were sequenced automatically after 
attachment of 2-amino-l,5 naphthalene disulfonic 
acid to the C-terminal residue [ 171. Phenylthio- 
hydantoin (PTH) derivatives of amino acids were 
analyzed by gas chromatography [ 181, thin-layer 
chromatography on silica plates [ 191 and by amino 
acid analysis after conversion of the PTH derivatives 
into free amino acids by hydrolysis with HI [20]. 
Halfcystine residues were identified as S-[ 14C] car- 
boxymethyl derivatives by liquid scintillation 
counting. 
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Fig.1. Amino acid sequence of VL K16-167. The indicated large peptides (A and B) were isolated from a Bio-Gel A,.sm column 
in 5 M guanidine hydrochloride after tryptic digestion of the citraconylated light chain. Tryptic peptides T, and T, were 
obtained from fragment B after decitraconylation and isolated by high-voltage paper electrophoresis. 
3. Results 
The amino acid sequence of the VL region of 
rabbit antibody 16-l 67 is displayed in fig. 1. The 
N-terminal 47 amino acid residues were established 
by automated sequencing of the intact light-chain. 
The repetitive yield in this sequenator run was 94%. 
Amino acid analysis of the entire light-chain (not 
shown) indicated the presence of two arginine residues. 
Advantage was taken of this fact by succinylation 
and tryptic digesiton of the light-chain followed by 
dialysis against distilled water, lyophilization and 
automated sequencing of the mixture. The.finding of 
a single ammo acid sequence confirmed the presence 
of only one arginine residue in the VL region indicat- 
ing that the second arginine (presumably in position 
207) was from the constant region [21]. Under these 
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Fig.2. Elution-profde of the tryptic digest of the citra- 
conylated VL K16-167 on a Bio-Gel A,., m column 
(2 X 180 cm). Fragments A and B are indicated. 
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conditions the C-terminal tripeptide Gly-Asp-Cys 
was presumably dialysed out. It could be shown by 
homology with other rabbit K-chains (21-231 that 
the unblocked peptide of this mixture (peptide A in 
fig.2) starts with phenylalanine in position 63 and 
comprises the third hypervariable region and the 
constant part of the chain. Peptide A and peptide B, 
which comprises the 62 N-terminal residues of the 
light-chain, moreover were obtained by tryptic 
digestion of the citraconylated light-chain and 
separation on Bio-Gel Ar.s m in 5 M guanidine hydro- 
chloride (fig.2). After decitraconylation and tryptic 
digestion of fragment B, two relevant peptides (Tr 
and Tz) were isolated by high-voltage paper electro- 
phoresis: Their ammo acid sequences were established 
by automated Edman degradation, as described in 
Materials and methods, and by hydrolysis with 
carboxypeptidases A and B (fig.]). 
Peptide Ts starting with phenylalanine in position 
63 and comprising the third hypervariable region up 
to lysine in position 107 was isolated, after decitra- 
conylation and tryptic digestion of peptide B, by two 
cycles of gel-filtration on Sephadex G-50 in 5 M 
guanidine hydrochloride. The C-terminal sequence of 
this peptide was established by time-dependent diges- 
tion with carboxypeptidases A and B (fig.1). 
4. Discussion 
The primary structure of the VL of rabbit antibody 
K16-167 was established by sequencing 4 different 
peptides, i.e., the N-terminus of the intact chain, the 
N-terminus of a large peptide starting with phenyl- 
alanine in position 63 and ending with the C-terminal 
arginyl residue (position 207) of this chain, and two 
Table 1 
Degree (%) of homology of rabbit and human VL regions 
Hypervariable positions 
Anti-Av-CHO Anti-WI V,I V,II V,III V,IV 
K16-167 
K4820 
Kg-335 
BS-1 
BS-5 
K-25 
Roy 
Tew 
Ti 
Len 
_ 
I .- 
K16-167 K4820 Kg-335 BS-1 BS-5 K-25 Roy Tew Ti Len 
- 71 79 62 
81 - 67 58 
84 80 - 58 
80 86 82 - 
80 85 82 98 
81 86 77 88 
64 70 59 70 
56 57 57 56 
60 57 59 62 
60 63 66 66 
67 54 29 
62 54 42 
67 58 29 
75 71 37 
- 67 50 
86 - 42 
70 69 - 
57 53 61 
62 57 60 
66 63 73 
31 17 29 
29 46 29 
25 33 33 
21 37 29 
21 37 42 
25 50 33 
10 43 18 
- 24 32 
72 - 32 
77 76 - 
Hypervariable positions, numbering scheme according to Schneider and Hilschmann [ 241. Positions were aligned to 
maximal homology. Deletions were taken as identical positions. 
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small tryptic peptides, one overlapping with the 
N-terminal sequence. Since rabbit anti-Av-CHO anti- 
bodies do not display a second hypervariable region 
[4] no difficulties occurred with the positioning of 
the peptides by homology with other rabbit light- 
chain sequences [4,21-231. 
The degrees of homology of VL of antibody 
K16-167 to human light-chains of subgroups I-IV 
[25] and to VL of rabbit antibodies are shown in 
table 1. Within invariant positions (framework) rabbit 
light-chains share between 77-98% homology, 
whereas human light-chains of different subgroups 
share only 61-77% homology; human and rabbit 
light-chains share between 53% and 70% homology. 
The analysis of similarities within the 3 hypervariable 
or complementarity-determining regions [25] 
indicates 1 O-43% homology between human light- 
chain hypervariable regions and 17-50% homology 
between human and rabbit hypervariable regions. 
Hypervariable regions of rabbit light-chains derived 
from anti-Av-CHO antibodies, however, share 
between 67% and 79% homology (the sequences of 
light chains K4820 and K9-335 are taken from ref. 
[4]). This high extent of homology is partly due to 
the number of deletions in the first hypervariable 
section which were taken as identical positions. In 
view of the possible importance of the chain-length 
for the formation of the combining site [26] this 
assumption seems to be justified. Moreover, it has to 
be considered that rabbit light-chains lack a second 
hype,rvariable region [4]. If the comparison is there- 
fore restricted to positions of the first and third 
hypervariable regions, still 53%, 59% and 7 1% 
homology are observed between the three light-chains 
K4820, K16-167 and K9-335 derived from anti-Av- 
CHO antibodies. 
The comparison of light-chain hypervariable 
regions of rabbit anti-Av-CHO and anti-Type III 
pneumococcal polysaccharide (SIII) antibodies, 
indicates between 54% and 67% homology, whereas 
among hypervariable regions of anti-SRI antibodies 
67-7.5% homology is noted, which is similar to 
the homology observed among anti-Av-CHO anti- 
bodies. It thus appears that light-chains derived from 
rabbit antibodies with the same binding activity 
show a slightly higher degree of homology within 
their hypervariable regions than rabbit antibodies 
with different binding activities. In addition a higher 
extent of homology is noted among hypervariable 
regions of different light-chains derived from rabbit 
anti-polysaccharide antibodies than among hyper- 
variable regions of human light-chains or across the 
two species. The variability of anti-polysaccharide 
rabbit antibody VL regions is therefore less than that 
of randomly chosen immunoglobulin light-chains 
but more than that of heavy-chain variable regions of 
anti-phosphoryl-choline antibodies (for reference see 
[271). 
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